Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can nanozymes achieve more than enzymes?

Nature reviews. Materials·2026
Same author

Correction: Controlled intra- and extracellular localization of bioorthogonal polymeric nanozymes.

Chemical science·2026
Same author

Controlled intra- and extracellular localization of bioorthogonal polymeric nanozymes.

Chemical science·2026
Same author

Engineered Lipid Coronas for Gold Nanoparticle-Based Bioorthogonal Catalysis.

Nano letters·2025
Same author

Controlled bioorthogonal catalyst self-assembly and activity using rationally designed polymer scaffolds.

Nanoscale·2024
Same author

Engineering of bioorthogonal polyzymes through polymer sidechain design.

Journal of polymer science (2020)·2024

Related Experiment Video

Updated: Aug 9, 2025

Preparation of Functional Silica Using a Bioinspired Method
08:04

Preparation of Functional Silica Using a Bioinspired Method

Published on: August 1, 2018

17.3K

Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.

Cristina-Maria Hirschbiegel1, Xianzhi Zhang1, Rui Huang1

  • 1Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St, Amherst, MA 01003, USA.

Advanced Drug Delivery Reviews
|February 15, 2023
PubMed
Summary

Bioorthogonal transition metal catalysts (TMCs) on inorganic nanoscaffolds act as "drug factories." These nano-factories activate pro-drugs at disease sites, enhancing targeted therapy and minimizing side effects.

Keywords:
Bioorthogonal catalysisGadolinium nanoclustersGold nanoparticlesInorganic nanomaterialsMagnetic iron oxide nanoparticlesMetal–organic frameworksMolybdenum disulfide nanosheetsSilica nanoparticlesSurface functionalizationTitanium dioxide nanoparticles

More Related Videos

Synthesis of Metal Nanoparticles Supported on Carbon Nanotube with Doped Co and N Atoms and its Catalytic Applications in Hydrogen Production
08:40

Synthesis of Metal Nanoparticles Supported on Carbon Nanotube with Doped Co and N Atoms and its Catalytic Applications in Hydrogen Production

Published on: December 6, 2021

3.6K
Ultrahigh Density Array of Vertically Aligned Small-molecular Organic Nanowires on Arbitrary Substrates
08:07

Ultrahigh Density Array of Vertically Aligned Small-molecular Organic Nanowires on Arbitrary Substrates

Published on: June 18, 2013

15.1K

Related Experiment Videos

Last Updated: Aug 9, 2025

Preparation of Functional Silica Using a Bioinspired Method
08:04

Preparation of Functional Silica Using a Bioinspired Method

Published on: August 1, 2018

17.3K
Synthesis of Metal Nanoparticles Supported on Carbon Nanotube with Doped Co and N Atoms and its Catalytic Applications in Hydrogen Production
08:40

Synthesis of Metal Nanoparticles Supported on Carbon Nanotube with Doped Co and N Atoms and its Catalytic Applications in Hydrogen Production

Published on: December 6, 2021

3.6K
Ultrahigh Density Array of Vertically Aligned Small-molecular Organic Nanowires on Arbitrary Substrates
08:07

Ultrahigh Density Array of Vertically Aligned Small-molecular Organic Nanowires on Arbitrary Substrates

Published on: June 18, 2013

15.1K

Area of Science:

  • Bioinorganic Chemistry
  • Nanotechnology
  • Catalysis

Background:

  • Bioorthogonal transition metal catalysts (TMCs) are crucial for converting inactive pro-drugs into active compounds.
  • Inorganic nanoscaffolds offer protection, solubility, and design flexibility for TMCs.
  • Current limitations include off-target effects and catalyst stability.

Purpose of the Study:

  • To review the use of inorganic nanoscaffolds for housing bioorthogonal transition metal catalysts.
  • To explore the potential of these nanoscaffold-TMC systems as localized drug-activating "drug factories."
  • To discuss the in vitro and in vivo applications of these bioorthogonal nanozymes.

Main Methods:

  • Encapsulation of TMCs within diverse inorganic nanoscaffolds.
  • Design of nanoscaffolds for catalyst protection, solubilization, and targeted delivery.
  • Integration of stimuli-responsive elements for controlled drug activation.

Main Results:

  • Inorganic nanoscaffolds enhance TMC stability and selectivity, enabling enzyme-like bioorthogonal reactions.
  • Nanoscaffold design allows for decoration with targeting moieties and stimuli-responsive functionalities.
  • These systems facilitate in situ pro-drug activation, localizing therapeutic effects.

Conclusions:

  • Inorganic nanoscaffolds are versatile platforms for developing advanced bioorthogonal nanozymes.
  • These nano-factories offer a promising strategy for targeted drug delivery and activation.
  • Further exploration of in vitro and in vivo applications is warranted for clinical translation.